Skip to main content
India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials - Fossbytes 02-Jul-2020
India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials - Fossbytes
Covaxin contains a weakened version of the SARS-CoV-2 virus (Coronavirus) which will be injected into the patient's body to elicit an immune response. India’s COVID-19 vaccine has been developed by the combined efforts of Bharat Biotech, Indian Council of Med…
More...